About CARDAX INC
Sector
CEO
David G. Watumull
Headquarters
Honolulu
Website
Founded
2014
ISIN
US14141D2018
FIGI
BBG0032KT2Z2
Cardax, Inc. is a development stage biopharmaceutical company, which engages in development of pharmaceuticals for chronic diseases driven by inflammation. The firm focuses on astaxanthin, a powerful and safe naturally occurring anti-inflammatory without the side effects of currently marketed anti-inflammatories. Its product platform includes pharmaceutical candidates CDX-101 and CDX-301, and dietary supplement, ZanthoSyn. The company was founded on February 7, 2014 and is headquartered in Honolulu, HI.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CDXI is 0.000001 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CARDAX INC stocks are traded under the ticker CDXI.
CARDAX INC is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
CDXI stock is 0% volatile and has beta coefficient of −4.55. Check out the list of the most volatile stocks — is CARDAX INC there?
Yes, you can track CARDAX INC financials in yearly and quarterly reports right on TradingView.
No, CDXI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CDXI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARDAX INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARDAX INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARDAX INC stock shows the sell signal. See more of CARDAX INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.